Excalipoint Therapeutics
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases
$27.7MSeed+
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation T-cell engager therapies for cancer and autoimmune diseases
Helps teams build deploy and operate production-grade AI applications and agentic workflows
Pitching 5Y Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room